This results in LVD being evaluated using several antibodies including D2-40, podoplanin, and VEGFR3 and by several techniques including the single most positive high-powered field (hot-spot), the invasive tumor front, the tumor center and combinations of these. The gene discussed is PDPN; the disease is neoplasm.